Compare stocks

Cegedim SA is a French company specializing in the healthcare technology and services industry. It provides software, databases, and services to healthcare professionals, insurers, and pharmaceutical companies, focusing on solutions that enhance operational efficiency and data management. The company offers products such as customer relationship management (CRM) solutions, electronic health records, and healthcare data analytics. Founded in 1969, Cegedim is headquartered in Boulogne-Billancourt, France, with operations extending across multiple countries. It holds a competitive position through its comprehensive suite of integrated solutions tailored for the healthcare sector.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio, while the 2026 acquisition of Apogee adds to AbbVie's immunology depth.